Cargando…

Nintedanib (BIBF 1120) for IPF: a tomorrow therapy?

Idiopathic pulmonary fibrosis is a rare, life threatening disease characterized by an anarchic fibrogenesis, limited survival and few therapeutic options. Its pathogenesis is complex and involves the interaction among various pathways driven by proinflammatory/profibrogenetic mediators such as plate...

Descripción completa

Detalles Bibliográficos
Autor principal:	Antoniu, Sabina A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541099/ https://www.ncbi.nlm.nih.gov/pubmed/23146151 http://dx.doi.org/10.1186/2049-6958-7-41

Ejemplares similares

Efficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivo
por: Xue, Cong, et al.
Publicado: (2016)

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)
por: Huang, Ruby Yun-Ju, et al.
Publicado: (2015)

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond
por: Gori, Bruno, et al.
Publicado: (2011)

BIBF1120 Protects against Diabetic Retinopathy through Neovascularization-Related Molecules and the MAPK Signaling Pathway
por: Cao, Xin, et al.
Publicado: (2023)

Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients
por: Bousquet, G, et al.
Publicado: (2011)

PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
por: Fazio, Grazia, et al.
Publicado: (2022)

Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl(4)-induced liver fibrogenesis mouse model
por: Öztürk Akcora, Büsra, et al.
Publicado: (2017)

Colitis Associated with Nintedanib Therapy for Idiopathic Pulmonary Fibrosis (IPF)
por: Oda, Keishi, et al.
Publicado: (2017)

Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials
por: Noth, Imre, et al.
Publicado: (2019)

South–West of England’s Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
por: Barratt, Shaney L., et al.
Publicado: (2018)

Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
por: Finnerty, James Patrick, et al.
Publicado: (2021)

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial
por: Maher, Toby M, et al.
Publicado: (2018)

Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials
por: Kreuter, Michael, et al.
Publicado: (2020)

Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study
por: Raman, Lavanya, et al.
Publicado: (2023)

Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension
por: Richeldi, Luca, et al.
Publicado: (2018)

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
por: Jo, Helen E., et al.
Publicado: (2019)

Recommendations on treatment for IPF
por: Behr, Jürgen, et al.
Publicado: (2013)

P1120: THE EFFICACY AND SAFETY OF ZANUBRUTINIB AND DEXAMETHASONE IN SYMPTOMATIC WALDENSTROM MACROGLOBULINNEMIA
por: Liu, A., et al.
Publicado: (2022)

Highlights of HRCT imaging in IPF
por: Sverzellati, N
Publicado: (2013)

The tomorrow of malaria
por: Dobson, Mary J
Publicado: (1997)

New 11,20-Epoxybriaranes from the Gorgonian Coral Junceella fragilis (Ellisellidae)
por: Lin, Chia-Cheng, et al.
Publicado: (2019)

Abstract: 11.20 The Potential Of Adipose Derived Stem Cells For Chronic Wounds
por: Rafik, Amine, et al.
Publicado: (2017)

Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
por: Wind, Sven, et al.
Publicado: (2019)

Selecting Tomorrow’s Doctors
por: Steele, Keith
Publicado: (2011)

Mitochondrial Quality Control in COPD and IPF
por: Hara, Hiromichi, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis (IPF): An Overview
por: Barratt, Shaney L., et al.
Publicado: (2018)

Microbiota and IPF: hidden and detected relationships
por: Fabbrizzi, Alessio, et al.
Publicado: (2021)

Bacterial proteins and peptides in cancer therapy: Today and tomorrow
por: Chakrabarty, Ananda M, et al.
Publicado: (2014)

Development of the ATAQ-IPF: a tool to assess quality of life in IPF
por: Swigris, Jeffrey J, et al.
Publicado: (2010)

Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice
por: Gurusamy, Malarvizhi, et al.
Publicado: (2023)

Gene Therapy Today and Tomorrow
por: Lundstrom, Kenneth
Publicado: (2019)

1120. Reliability of Parent-Reported Pediatric Antibiotic Use in a Longitudinal Birth Cohort
por: D’Arinzo, Lauren, et al.
Publicado: (2019)

Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013)

The hospital of tomorrow in 10 points
por: Vincent, Jean-Louis, et al.
Publicado: (2017)

1120. Impact of Training Residents to Improve HIV Screening in a Teaching Hospital in Mexico City
por: Guerrero-Torres, Lorena, et al.
Publicado: (2020)

Nintedanib in advanced NSCLC: management of adverse events
por: Lemmens, Liesbeth
Publicado: (2016)

Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF
por: Tóth, Nóra Melinda, et al.
Publicado: (2023)

Evaluation of forensic and anthropological potential of D9S1120 in Mestizos and Amerindian populations from Mexico
por: Rangel-Villalobos, Héctor, et al.
Publicado: (2012)

Opioids: an unexplored option for treatment of dyspnea in IPF
por: Kohberg, Charlotte, et al.
Publicado: (2016)

Bibliotheca Medica: Physician for Tomorrow
por: Truelson, Stanley D.
Publicado: (1967)

Cannot write session to /tmp/vufind_sessions/sess_rpp972kf1ttohv8gt2kpfp5u65